Fights viruses, bacteria, mold, odors, and insects in the air and on surfaces
Continuously flows through any indoor space
Certified to meet UL2998 for zero ozone emissions, so no one ever has to leave the room
Validated by peer-reviewed published studies

Proven from peer-reviewed, published studies and rigorous lab tests.

Synexis BioDefense System showed effective reduction against every species of microbes it was tested against. And since our DHP™ flows continuously, when we attack one, we’re attacking every susceptible microbe. Unlike others, these are controlled studies in room-sized laboratories and include data obtained from lab tests.

  • 0% reduction of SARS-CoV-21

    Shown effective on surfaces vs. control at 2 hours and published in the American Journal of Infection Control (AJIC). A similar study showed that DHP™ reduced MS2 (a coronavirus surrogate) in the air by >99% at 60 minutes.2

  • 0% reduction of bacteria3

    From collecting environmental surface samples after one day, an independent study was conducted in a 762-bed acute care facility and published in AJIC.

  • 0% reduction of E. Coli and Influenza4,5

    Shown effective vs control at 60 minutes. Our data spans a variety of other viruses and bacteria, including significant reduction of Staphylococcus (MRSA), Salmonella, norovirus and more.

  • 0% significant reduction shown in mold6,7

    Including >99.9% in-air reduction at 2 hours and 90.8% surface reduction at 24 hours in A. niger (A. brasiliensis), which causes black mold.

Studies in American Journal of Infection Control.

Impact of Dry Hydrogen Peroxide on Hospital-Acquired Infection at a Pediatric Oncology Hospital8

This study published in AJIC describes the effect of DHP™ as an adjunct technology to environmental cleaning and disinfection on the incidence of HAIs in a pediatric oncology hospital. The addition of 24-hour, continuous DHP™ reduced the odds of contracting an HAI by 61.4%.

Treatment with Dry Hydrogen Peroxide Accelerates the Decay of Severe Acute Syndrome Coronavirus-2 on Non-porous Hard Surfaces1

An independent lab study showed that DHP™ can significantly reduce infectious SARS-CoV-2 on contaminated surfaces—and that DHP™ Technology can be considered an effective and dynamic method to reduce the presence of SARS-CoV-2 during the pandemic of COVID-19.

Evaluation of DHP™ in Reducing Microbial Bioburden in a Healthcare Facility3

In a clinical study, DHP™ demonstrated a statistically significant 96.5% reduction, with the greatest difference seen on soft surfaces, but also showed significant reduction in mean microbial air sample counts.

Effectiveness of DHP™ on Reducing Environmental Microbial Bioburden Risk in a Pediatric Oncology Intensive Care Unit

This clinical study analyzed surface samples before and after DHP™ was deployed, and demonstrated that the overall mean surface microbial burden was significantly reduced.

DHP™ Technology for Reduction of Microbial Colonization in the Hospital Setting

After incorporating DHP™ technology into a 34-bed Cardiovascular/Telemetry unit’s existing HVAC system, this study showed a significant reduction in microbes over seven days.

An Effective and Automated Approach for Reducing Infection Risk From Contaminated Privacy Curtains9

A study of curtain contamination in five different units using continuous DHP™ Technology showed that the microbial load was reduced by 99.47% on Day 1.

Study in Pharmacy Times.

Infection Specialists and Pharmacists Share Responsibility for Ensuring Patient Safety

A case report from an inpatient hospital determined that DHP™ technology continuously helps address active shedding and contamination in real time without disrupting pharmacy workflow.

A Taxonomy of Air-Cleaning Technologies Conducted by TRANE®

In an independent laboratory test, Synexis DHP™ showed significant reduction of MS2 (surrogate for the SARS-CoV-2) at various time periods, both in the air and on surfaces.

Reference: 1. Huang, Y.-J. S., Bilyeu, A. N., Hsu, W.-W., Hettenbach, S. M., Willix, J. L., Stewart, S. C., Higgs, S., & Vanlandingham, D. L. (2021). Treatment with Dry Hydrogen Peroxide Accelerates the Decay of Severe Acute Syndrome Coronavirus-2 on Non-porous Hard Surfaces. American Journal of Infection Control. 2. Data on File. SYN-0001. 3. Sanguinet, J., Edmiston, C., Evaluation of dry hydrogen peroxide in reducing microbial bioburden in a healthcare facility. American Journal of Infection Control. 2021 August. 4. Data on File. SYN-0005. 5. Data on File. SYN-0002. 6. Data on File. SYN-0006. 7. Data on File. SYN-0010. 8. Melgar, M., Ramirez, M., Chang, A., Antillon, F., Impact of Dry Hydrogen Peroxide on Hospital-Acquired Infection at a Pediatric Oncology Hospital, American Journal of Infection Control, 2021 December. DOI: 9. Sanguinet J, Lee C. An effective and automated approach for reducing infection risk from contaminated privacy curtains. American Journal of Infection Control. 2021 June;